Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| K01AG092253-01A1 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute on Aging (NIA) | NIH |
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to learn whether a group-based HIV prevention program can improve HIV knowledge, prevention behaviors, and testing in older Black women aged 50 and older who live in subsidized housing. The study focuses on improving how HIV prevention programs address the unique needs and life experiences of older Black women.
The main questions it aims to answer are:
Can a revised HIV prevention intervention tailored to reproductive health histories improve HIV knowledge, condom use, and testing in older Black women?
Is the intervention feasible, acceptable, and engaging for participants?
The PI will compare a group of participants receiving the Woman-2-Woman (W2W) intervention to a wait-listed control group to see if the intervention leads to better HIV prevention outcomes.
Participants will:
Join a group-based HIV prevention program designed for older Black women
Be randomly assigned to either:
Start the intervention right away, or
Join a waitlist and start the program 4 weeks later
Take part in four weekly sessions that include group discussions, education, and skill-building activities
Share information about their reproductive health histories and sexual health decisions during focus groups or surveys
Complete questionnaires at the start, after the program ends, and 4 weeks later to assess HIV knowledge, condom use, and testing behavior
This research aims to create a culturally tailored, evidence-based HIV intervention that fits the lives and needs of older Black women and can be used in future, larger studies.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Adapted W2W | Experimental | HIV intervention focused on aging-related HIV knowledge, identifying HIV prevention practices, and reducing HIV transmission. Intervention given in four, 2 hour educational sessions with a fifth booster session and a final follow up session. |
|
| Waitlist Control | Active Comparator | This group will receive the intervention 8 weeks after the W2W intervention group completes their follow-up and in the same pattern. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Adapted W2W | Behavioral | HIV education sessions and questionnaires. |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Recruitment rate | Feasibility will be measured by recruitment rate (number of participants who sign the informed consent divided by those participants who meet the eligibility criteria) | Baseline |
| Acceptability | Acceptability will be measured by program satisfaction evaluations. Participants rate statements (1-5) with higher scores equating to greater satisfaction. | Assessed at weeks 1,2,3,4, 8 and 12 |
| Retention Rate | Feasibility will also be measured by retention rate (number of participants who complete all 4 sessions divided by those participants who signed the informed consent) | Baseline (week 1) and Post-Intervention (Week 8) |
| Change in HIV Knowledge | HIV knowledge will be measured by the HIV-KQ-18. Scores range from 0-18 with higher scores equating to greater HIV knowledge. | Baseline (week 1), Post-Intervention (Week 8), and Study completion (Week 12) |
| Change in Condom-use self-efficacy (CUSES) | CUSES is a 28 item scale that will assess behavioral intentions and past behavior related to feelings about purchasing, using, and negotiating use of condoms with a new partner. Each item has a 5-point response format ranging from 0 (strongly disagree) to 4 (strongly agree). After reversing negatively worded items, scores range from 0-112 (with higher scores indicating more self-efficacy). | Baseline (week 1), Post-Intervention (Week 8), and Study completion (Week 12) |
| Change in H-AGE scale | The H-AGE scale is a gender and aging specific HIV knowledge scale with 6 items that assess participants knowledge of gender and age related issues regarding HIV. Q1 is a true/false question; Q2 & 3 are multiple choice questions; Q4 is rating of strongly disagree (1) to strongly agree (5); Q5 is rating very comfortable (1)to very uncomfortable (5); Q6 they select one from the following (positive, negative, mixed, neutral) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Laneshia Conner, PhD | Contact | 859-562-3355 | laneshia.conner@uky.edu |
| Name | Affiliation | Role |
|---|---|---|
| Laneshia Conner, PhD | University of Kentucky | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Kentucky | Lexington | Kentucky | 40506 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000073599 | Health Risk Behaviors |
| D006266 | Health Education |
| ID | Term |
|---|---|
| D015438 | Health Behavior |
| D001519 | Behavior |
| D000099060 | Adherence Interventions |
| D055118 | Medication Adherence |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Waitlist Control |
| Behavioral |
HIV education sessions and questionnaires given 4 weeks after W2W intervention. |
|
| Baseline (week 1), Post-Intervention (Week 8), and Study completion (Week 12) |
| D010349 |
| Patient Compliance |
| D010342 | Patient Acceptance of Health Care |
| D000074822 | Treatment Adherence and Compliance |